SQUAWK/NEWS
Menu
Live News EQUITY FLASH M impact

MiNK Therapeutics Presents Phase 2 Trial Observations

MiNK Therapeutics shares early Phase 2 trial results

INKT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.